{"count": 1, "results": [{"_id": "31977576", "pmid": 31977576, "title": "The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.", "journal": "J Hypertens", "authors": ["Juraschek SP", "Simpson LM", "Davis BR", "Shmerling RH", "Beach JL", "Ishak A", "Mukamal KJ"], "date": "2020-05-01T00:00:00Z", "doi": "10.1097/HJH.0000000000002359", "meta_date_publication": "2020 May", "meta_volume": "38", "meta_issue": "5", "meta_pages": "954-960", "score": 50267.473, "text_hl": "@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ nonsignificantly lowered @<m>DISEASE_Gout</m> @DISEASE_MESH:D006073 @@@gout@@@ risk compared with @CHEMICAL_Chlorthalidone @CHEMICAL_MESH:D002752 @@@chlorthalidone@@@ (hazard ratio 0.85; 95% CI 0.70--1.03). ", "citations": {"NLM": "Juraschek SP, Simpson LM, Davis BR, Shmerling RH, Beach JL, Ishak A, Mukamal KJ. The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. J Hypertens. 2020 May;38(5):954-960. PMID: 31977576", "BibTeX": "@article{31977576, title={The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.}, author={Juraschek SP and Simpson LM and Davis BR and Shmerling RH and Beach JL and Ishak A and Mukamal KJ}, journal={J Hypertens}, volume={38}, number={5}, pages={954-960}}"}}]}